Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
TransMedics Group Community
NasdaqGM:TMDX Community
1
Narratives
written by author
0
Comments
on narratives written by author
85
Fair Values set
on narratives written by author
Create a narrative
TransMedics Group
Popular
Undervalued
Overvalued
Community Investing Ideas
TransMedics Group
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Next-Gen Heart And Lung Programs Will Drive Deeper Market Adoption In 2025
Key Takeaways Expansion in logistics and clinical programs is set to significantly boost transplant volumes, revenue growth, and operational efficiency. Strategic innovations and scalability plans aim to enhance market penetration, improve net margins, and secure long-term market dominance.
View narrative
US$102.86
FV
34.2% undervalued
intrinsic discount
19.61%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
45
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
TMDX
TMDX
TransMedics Group
Your Fair Value
US$
Current Price
US$67.67
24.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-44m
931m
2015
2018
2021
2024
2025
2027
2030
Revenue US$930.7m
Earnings US$74.8m
Advanced
Set Fair Value